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Abstract
Cardiac resynchronization therapy has become a widely used procedure for the treatment of
patients with heart failure and severely impaired systolic function who associate left bundle
branch block and remain symptomatic, in New York Heart Association II to IV functional class,
despite maximum tolerated medical therapy. Imaging evaluation of these patients is complex,
aiming to provide an accurate and extensive assessment before and after implantation, although
a standardized protocol is yet to be implemented. Extensive research has been conducted to assess
the ability of different imaging techniques and parameters to identify and quantify mechanical
dyssynchrony, assess myocardial remodeling, provide prognostic information, or help guide lead
placement and pacing parameters optimization in this category of patients. For these purposes,
ultrasound-based imaging techniques, as well as cardiac magnetic resonance imaging, multislice
cardiac computed tomography and nuclear ventriculography have been and are currently used,
for research, as well as for clinical purposes. The aim of the current paper was to provide some
insights into the imaging assessment of candidates and patients who have undergone cardiac
resynchronization therapy.
Keywords: cardiac resynchronization therapy, mechanical dyssynchrony, echocardiography,
cardiac magnetic resonance imaging
1. The role of imaging techniques in assessing patients with cardiac
resynchronization therapy: general considerations
During the last two decades, cardiac resynchronization therapy (CRT) has become a valuable
therapeutic procedure for patients with heart failure (HF) due to dilated cardiomyopathy (DCM),
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improving prognosis, symptoms, quality of life, and ventricular function [1–6]. Current ESC
guidelines on cardiac pacing and CRT recommend the procedure as a class I indication in HF
patients with left bundle branch block (LBBB), QRS width ≥120 ms, and left ventricle ejection
fraction (LVEF) ≤35%, who remain in New York Heart Association (NYHA) functional class II,
III, and ambulatory IV despite optimal medical therapy [7].
According to these guidelines, patient selection mainly relies on clinical and electrocardiogram
(ECG) characteristics, while the role of echocardiography is limited to determining LVEF.
Despite this rather frugal approach, extensive research involving echocardiography and other
imaging techniques has been conducted over the last few years, with the purpose of improving
the selection and management of CRT candidates. Since CRT is still a rather expensive
procedure [8–10], and not entirely risk-free [11], even if performed by experienced electro-
physiologists, efforts were made to establish sound patient selection criteria, as well as to find
accurate methods, techniques, algorithms, and tools for prognosis assessment and pacing
optimization. As a consequence, a plethora of ultrasound imaging parameters for cardiac
mechanics and dyssynchrony evaluation have been developed, and expert consensus state-
ments were released [12, 13] in order to help clinicians choose the best therapeutic strategy.
Early studies on mechanical dyssynchrony parameters seemed somewhat promising. For
instance, Yu et al. attempted to prove that CRT was beneficial in patients who had echocar-
diographic evidence of mechanical dyssynchrony, even if they had narrow QRS complexes. In
their research, results were quite spectacular, raising hope that CRT indications might extend
beyond the recommendations of the guidelines [14]. Regrettably, the results of the much larger
Echocardiography Guided Cardiac Resynchronization Therapy (Echo-CRT) trial contradicted
these findings, highlighting the deleterious effects of CRT in patients with evidence of
mechanical dyssynchrony at echocardiography and narrow QRS complexes (QRS complex
duration <130 ms) [15].
In addition to that, the Predictors of Response to CRT (PROSPECT) trial tested the sensitivity
and specificity of 12 different echocardiography mechanical dyssynchrony parameters,
yielding disappointing results. The sensitivity and specificity of the studied parameters were
either too low or discordant, and, as consequence, none of them was acknowledged as being
clinically useful [16]. Sanderson JE challenged the results of the PROSPECT trial, stating that
this trial was rather a study of error and did not provide an accurate assessment of the
reproducibility and clinical value of mechanical dyssynchrony parameters; according to this
author, the results of the PROSPECT trial were justified by the fact that participating centers
were more focused on electrophysiology and lacked the technical possibilities and/or the
expertise for an appropriate echocardiographic assessment [17]. Bax and Gorcsan also found
flaws in the PROSPECT study, pointing out that among selected patients, 20.2% had an LVEF
>35% while 37.8% had end-diastolic dimensions <65 mm, and were therefore unlikely to
develop spectacular reverse remodeling since there was little remodeling and systolic function
impairment to begin with; in addition to that, they brought up technical issues, such as the fact
that ultrasound machines that have been used for the study came from three different vendors,
while also suggesting that the high interobserver variability in some parameters might have
been justified by the lack of a systematic examination protocol [18].
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As a consequence, there is currently not enough proof to either fully embrace or dismiss
myocardial dyssynchrony parameters. In fact, some studies have suggested that the evaluation
of cardiac mechanics by echocardiography may have quite an important role in optimizing
pacing parameters [19], choosing the most appropriate site for lead placement [20], and
assessing patient prognosis [21], particularly if advanced ultrasound imaging techniques, such
as speckle tracking, are used.
Data on the preferences of clinical practitioners are currently scarce. In a relatively recent
European survey, 68% of physicians in the responding centers declared that they only relied
on guideline criteria for selecting CRT patients, but 66% acknowledged using echocardiogra-
phy for pacing parameters optimization. Among these, 37% stated they used tissue Doppler
imaging, 20% used speckle tracking-based techniques, and only 10% used three-dimensional
echocardiography [22], with the latter two being less used, probably due to limited availability.
Besides that, it is important to remember that echocardiography examination of patients with
CRT is not limited to mechanical dyssynchrony assessment and must include a thorough study
of left ventricular (LV) systolic and diastolic dysfunction, mitral regurgitation, right chamber
structure and function, or the possibility of pulmonary hypertension. All these topics will be
further discussed in this chapter.
Beyond echocardiography, other imaging techniques, such as multislice detector computer
tomography (MDCT) or cardiac magnetic resonance imaging (CMRI), can be very useful in
the management of patients who are candidates for CRT. Evaluation by MDCT, for instance,
can safely exclude significant coronary artery disease [23] and accurately describe coronary
veins anatomy [24], which can facilitate lead placement. CMRI provides the advantages of very
accurate LVEF determination, the ability to identify the extent and location of fibrosis by late
gadolinium enhancement, and an extensive study of myocardial deformation and dyssyn-
chrony by tagging techniques [25].
2. Echocardiography parameters for the assessment of patients with CRT
2.1. Examination of the left chambers. LV size, systolic function and diastolic function. Left
atrial size and function
Echocardiographic assessment of left chamber dimensions and function in patients who are
candidates for CRT or have already been submitted to the procedure is essential.
Conventional bidimensional echocardiography can be used for measuring LV end-diastolic
(EDD) and end-systolic (ESD) diameters and, preferably, LV volumes, assessed by the biplane
Simpson’s modified method and indexed to body surface area [26]. To enhance the quality of
endocardial delineation, contrast agents can also be used, particularly if an extremely accurate
evaluation of regional myocardial motion is also desired [27, 28], while three-dimensional
echocardiography increases the accuracy of volumetric measurements by reducing errors due
to the foreshortening of the LV [26].
Echocardiography and Other Noninvasive Imaging Techniques in the Selection and Management of Patients...
http://dx.doi.org/10.5772/64594
37
LV dimensions were previously shown to predict the response to CRT. In the Multicenter
Automatic Defibrillator Trial-CRT (MADIT-CRT) for instance, an LV end-diastolic volume
(LVEDV) indexed to body surface area (BSA) ≥125 mL/m2 was associated with a favorable
response to CRT [29].
In a substudy of the Multisite Stimulation in Cardiomyopathies (MUSTIC) trial, EDD and EDS
were shown to decrease 3 months after CRT (7.3 ± 0.8–6.8 ± 0.8 cm, p < 0.001, and 6.2 ± 0.8–5.9
± 0.8 cm, p < 0.05, respectively), with further reduction after 12 months since device implan-
tation (by 8.4 ± 7.8 and 8.8 ± 7.8 mm, respectively, both p < 0.001), with better results in patients
with idiopathic DCM vs. patients with ischemic cardiomyopathy (8.9 and 9.8 mm, p < 0.01)
[30]. The Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study also yielded
significant reductions in EDD and ESD, as well as in LV mass at 6-month follow-up [31]. By
contrast, in the Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) trial,
no significant changes were recorded in neither LV dimensions, nor in LVEF, despite improved
quality of life scores and NYHA functional class [32]. However, most of the patients in this
trial had ischemic cardiomyopathy (64% vs. 36% with idiopathic DCM in the CRT-D group
and 75.8% vs. 26.4% in the implanted cardioverter-defibrillator group) [32], which is very likely
to have confounded results, since ischemic etiology [29, 33, 34] and the presence of scar tissue
[35] and non-viable myocardium [36] are known predictors of limited response to CRT and
reverse remodeling.
As previously mentioned, LVEF is the single echocardiographic parameter that has been
accepted as a CRT patients’ selection criterion in current guidelines [7], and the cutoff value
has been established at 35%. LVEF has proved to be one of the most important parameters for
assessing the success of CRT in all major clinical trials, as well as smaller studies that addressed
this issue [37–44]. In MADIT-CRT despite more reduction in LV dimensions in the LVEF >30%
group, clinical outcomes were similar in patients with lower LVEF [45]. A subanalysis of data
from the REVERSE trial revealed similar extents of reverse remodeling and clinical benefits in
patients who had LVEF <30% vs. LVEF >30%, which may be justified by the fact that, unlike
patients included in the MADIT-CRT trial, patients in REVERSE only had mild HF [38].
Interestingly, responders to CRT [38] and particularly super-responders in whom the LVEF
becomes >50% [46] have an excellent prognosis, with a reduced number of ventricular
tachyarrhythmias and good clinical progression at 2.2 years; the authors concluded that, in
such patients, switching off the ICD function to prevent inadequate therapies from the device
might be considered.
Highlighting regional kinetic abnormalities by echocardiography could also be an important
issue, considering the fact that it may help identify patients with ischemic DCM, which is
associated with poorer outcomes after CRT and less reverse remodeling [29–36, 47].
Moreover, diastolic function assessment is not less important in this category of patients, since
it was shown to improve after CRT, in parallel with the LVEF [47] and particularly in respond-
ers [48]. Diastolic dysfunction has been previously assessed by either conventional echocar-
diography, including parameters such as transmitral flow waves velocities and E-wave
deceleration time, diastolic myocardial velocities, the E/e’ ratio, diastolic filling duration, or
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isovolumic relaxation time, evaluated by pulsed wave and tissue Doppler imaging [48, 49], or
advanced techniques, such as speckle tracking [50, 51].
During the last decade, left atrium (LA) dimensions, particularly LA indexed volume (LAVI)
[52] and LA function, have become an important part of LV diastolic function assessment and
studies exploring the use of these parameters in CRT patients have recently been published
[53–59]. For instance, the MADIT-CRT trial showed significant reductions in LAVI in CRT-D
vs. ICD-only patients [53]. Major improvements in LAVI 3–6 months after CRT have also been
reported by Yu [54], Aksoy [55], and D’Andrea et al., the latter also showing better results in
patients with idiopathic DCM, by comparison with ischemic DCM patients [56]. In addition
to that, MADIT-CRT results highlighted the value of LAVI <40 ml/m2 as a predictor of clinical
response [29], which is also endorsed by Yu et al. who reported lower LAVI in responders [54].
In both the MADIT-CRT trial [53] and in the research by Kloosterman et al., increased preim-
plantation LAVI was associated with increased risk of HF progression and death, independ-
ently of LV volumes [57]. Other studies approached LA myocardial strain assessment in
patients with CRT, suggesting its prognostic value in assessing the risk for atrial fibrillation
development [58] or the response to CRT [59].
2.2. Right ventricular size and function evaluation: pulmonary hypertension assessment
by echocardiography
Although the assessment of left chambers is essential in patients who are candidates for CRT
or have undergone the procedure already, right chamber evaluation should not be overlooked.
Echocardiography-based studies on the topic are scarce, since bidimensional ultrasound
imaging has to overcome the obstacles posed by the complex anatomy of the right ventricle
(RV). Volumetric measurements can be flawed due to gross geometrical assumptions, since
the anatomic shape of the RV hardly resembles any geometric figure, and trabeculations of the
RV free wall can hinder adequate tracings of myocardial borders. Also, normal values have
not been firmly established for some right chamber parameters, such as the right atrium (RA)
volume, which currently remains, however, the preferred parameter for assessing RA size [60],
replacing RA area [26].
Despite these caveats, right chamber evaluation by echocardiography, as well as pulmonary
artery pressure estimation following current guidelines [61], can and should be performed in
CRT patients, as evidence regarding these parameters has started to accumulate, and right
chamber dilatation has been shown to associate with higher mortality in HF patients [62].
Data from radionuclide ventriculography studies suggest that impaired RV systolic function,
with RV ejection fraction ≤20%, is an independent predictor of mortality and hospitalization
due to HF [63], and that poorer systolic function is associated with a lower response rate after
CRT [65], accordingly, the evaluation of right chambers may have a certain role in selecting
patients for CRT. Moreover, increased RA area and impaired myocardial deformation of the
AD were proven to be negative predictors of response to CRT, as were ischemic DCM and low
intraventricular asynchrony [65].
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In the MADIT-CRT trial, RV ejection fraction was considerably improved, and patients with
the highest values had the lowest rate of adverse events at one year [66].
2.3. Mitral regurgitation assessment
Mitral regurgitation is another target for echocardiographic assessment in chronic HF patients,
since it has been shown to alter prognosis [67, 68]. In DCM, mitral regurgitation is usually
functional, developing as a consequence of mitral annulus dilatation, but mostly due to the
change of balance between tethering forces, pulling the leaflets towards the LV, and the forces
that favor normal closure of the mitral valve. Tethering forces are amplified by LV remodeling
and dilatation which result in an increased sphericity index and papillary muscle displace-
ment. In addition to that, the normal closure of the mitral valve is impaired by the reduction
of myocardial contractility and by ventricular contraction dyssynchrony [69], particularly in
the presence of LBBB [70].
Quantifying mitral regurgitation in these patients can be challenging, since the regurgitation
jet is often eccentric and should include measurements of vena contracta, the tenting area, as
well as of the area of regurgitant orifice and the regurgitation volume by the proximal
isovelocity surface area (PISA) method, when it is feasible. The extensive evaluation of mitral
regurgitation should be completed by a thorough evaluation of the ventricular function and
the asynchrony of contraction [71].
One study by Kanzaki et al. revealed the significant reduction of mitral regurgitation imme-
diately after CRT [70], which was most likely caused by contraction synchrony recovery.
Similar results have been reported by Breithardt et al. [72]. Moreover, LV reverse remodeling
and diminished tethering forces were shown to contribute to reducing mitral regurgitation on
the long term [73]. As far as short-term evolution is concerned, more data emerged supporting
mitral regurgitation dependency on ventricular dyssynchrony, as one study proved its
reduction after CRT, but also highlighted the fact that switching off the CRT device aggravates
the regurgitation even if the event occurs six months after implantation [74]. A similar,
although smaller study, also reported the reversal of mitral regurgitation, suggesting that CRT
should be continued indefinitely [75]. For these reasons, it is reasonable to take into account
mitral regurgitation reduction as a criterion for procedure success, particularly since it is
associated with clinical response [76–77].
Mitral regurgitation assessment should be done carefully and accurately in non-responders,
since some of these might benefit from further interventional treatment by MitraClip, which
was shown to reduce symptoms and promote LV reverse remodeling [78], or by surgical mitral
annuloplasty [79].
2.4. Dyssynchrony parameters evaluation
2.4.1. Clinical utility
Cardiac mechanics assessment by echocardiography is currently considered a challenge, and
research in the field has been extensive and endorsed by newly emerging techniques. However,
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despite all research efforts, none of the explored dyssynchrony parameters had proved to be
solid and reproducible enough for predicting the response to CRT, and, thus, for helping in
patients’ selection. Data from the CARE-HF study supported the use of echocardiographic
dyssynchrony parameters, showing that patients who had altered values responded better to
CRT [80], and had more reverse remodeling [81, 82]. In addition to that, Penicka et al., for
instance, proved that both the parameters for interventricular and intraventricular dyssyn-
chrony, assessed by tissue Doppler, were predictors of reverse remodeling and functional
recovery of the LV [83].
As previously mentioned, the PROSPECT trial challenged the accuracy of echocardiographic
dyssynchrony parameters [16] and was challenged in its turn by some authors [17, 18].
More recent and elaborate techniques motivated researchers to go further in the attempt to
find the optimal parameters for dyssynchrony quantification. Suffoletto et al. explored the
advantages of the speckle tracking technique, showing that radial dyssynchrony assessed by
this method predicted the response to CRT on long and short term [84]. The evaluation of
global strain [85], as well as the evaluation of longitudinal, circumferential, and radial strain
by tissue Doppler, also provided encouraging results [86]. However, these methods are costly,
not available in many clinical centers and time-consuming, requiring strenuous offline
analysis.
More available methods, such as tissue Doppler, are, unfortunately, hindered by lower
reproducibility in DCM patients, by comparison with normal individuals, probably due to the
complex contraction movements of the dilated heart and the method’s lack of standardization
[87].
The controversy regarding the echocardiographic evaluation of ventricular dyssynchrony
extends over their use for optimizing pacing parameters in CRT patients. Some electrophysi-
ologists prefer out-of-the-box settings and only adjust delays if the patients are non-respond-
ers. This attitude is endorsed by the quite large SMART-AV (The SmartDelay Determined AV
Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization
Therapy) trial in which 1014 patients were enrolled; in this study, the ECG-based SmartDelay
optimization algorithm, as well as echocardiography, did not show any benefit for optimiza-
tion by comparison with the out-of-the box approach in which a standard atrio-ventricular
delay of 120 msec was established [88]. Similar results emerged from smaller studies, such as
the one by Sawhney et al. who compared the effects of pacing with out-of-the-box delays with
those chosen after Doppler echocardiography, revealing quality of life and functional NYHA
class improvement, without significant changes in LVEF and 6-minute walk test distance [89].
In a larger study, on 215 patients, delay adjustments only provided additional benefit in a low
number of patients [90]. Vidal et al. also approached this issue, reporting minimal benefits in
patients with optimized parameters [91]. A retrospective analysis of multicentric trials
endorses the use of adaptive CRT, based on ambulatory measurements of intrinsic conduction,
in addition to conventional echocardiographic assessment, for optimization [92].
Although there is no consensus regarding the correct approach on the necessity and benefit of
optimization, or the appropriate means to perform it, American guidelines for the echocar-
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diographic assessment of CRT patients released by the American Society of Echocardiography,
endorsed by the Heart Rhythm Society, recommends considering echocardiography for pacing
parameters adjustment [12]. Accordingly, for adjustment of atrio-ventricular delays, the
guidelines suggest the evaluation of the transmitral flow by pulsed wave Doppler, based on
the premises that a long delay can lead to E and A wave fusion, diastolic mitral regurgitation,
and exposes the patient to the risk of native conduction that may lead to loss of resynchroni-
zation. On the other hand, an abnormally short atrio-ventricular delay can result in a truncated
A wave, as a consequence of premature closure of the mitral valve [12]. The Ritter method and
the iterative method are suggested as optimization algorithms [12, 92, 93]. For ventriculo-
ventricular delay adjustment, the guidelines recommend measurements of the aortic velocity
time integral after modifying the delay by 20 ms, starting with the maximal pre-excitation of
the LV [12].
For adjusting both delays, a fast algorithm was suggested—QuickOpt—available on St Jude
Medical devices, that was proved inferior to echocardiographic evaluation [94].
2.4.2. Cardiac mechanics evaluation parameters
Echocardiographic dyssynchrony evaluation protocols may differ from center to center
according to logistics, the available ultrasound machines and softwares, as well as the experi-
ence of the examiners and the number of hospitalized CRT patients. Since dyssynchrony
evaluation methods are not perfectly standardized, the choice of assessment parameters can
be influenced by the examiner’s opinion or the particularities of the case.
Figure 1. Transmitral flow assessment. Measurements of diastole and cardiac cycle duration.
Atrio-ventricular dyssynchrony criteria [12, 13]:
• duration of diastole—duration of diastolic filling measured on the pulsed wave Doppler
transmitral flow, from the onset of the E wave until the end of the A wave, at a sweep speed
of 100 cm/s;
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• duration of the cardiac cycle—measured using identical tags on successive QRS complexes;
• duration of diastole to cardiac cycle ratio; values <40% suggest atrio-ventricular dyssyn-
chrony (Figure 1);
• assessment of fusion of the E and A waves on the transmitral flow or the truncated A wave
[12, 13].
Figure 2. Septal-to-posterior wall motion delay measurement, using color M-mode imaging, from the parasternal
short-axis view at papillary muscle level.
Intraventricular dyssynchrony criteria
• SPWMD (septal-to-posterior wall motion delay)—the delay between the maximal contrac-
tion of the posterior wall and the maximal contraction of the septum or anterior wall (Figure
2); SPWMD can be measured using either M-mode, or, preferably, color M-mode, from the
parasternal short-axis view; values ≥130 msec suggest intraventricular dyssynchrony [12,
13]; Pitzalis et al. demonstrated the utility of this parameter as a predictor of remodeling
after CRT [95].
• Q-MI: the time interval from the onset of the QRS complex to the onset on the transmitral
flow, assessed by pulsed wave Doppler at a sweep speed of 100 cm/s [12, 96];
• Q-PW: the time interval from QRS onset until the maximum contraction of the LV posterior
wall, evaluated by color M-mode, at a sweep speed of 100 cm/s [12, 96];
• The (Q-PW)—(Q-Mi) difference—negative values are considered normal (in the absence of
intraventricular dyssynchrony, the maximum contraction of the LV posterior wall occurs
before mitral valve opening) (Figure 3) [96];
• Aortic pre-ejection time (A-PEP)—measured from the onset of the QRS complex until the
onset of the aortic flow, evaluated by pulsed wave Doppler from the apical five-chamber
view at a sweep speed of 100 cm/s; values above 140 ms suggest intraventricular dyssyn-
chrony [96];
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• Measurements of delayed mechanical activity by tissue Doppler analysis of opposing walls
motion (interventricular septum, lateral wall; anterior wall, inferior wall) using the apical
two- and four-chamber views (Figure 4); measurements should be performed on minimum
3–5 cardiac cycles and in post-expiratory apnea; differences ≥65 ms predict the acute
hemodynamic response post-CRT [83, 97, 98];
• Spectral tissue Doppler assessment of contraction delay between opposing LV walls; images
are acquired from the apical two- and four-chamber views; the sample volume is placed
1 cm below the mitral annular plane, guided by color tissue Doppler, with narrow sector;
the time interval from the onset of the QRS complex until maximal systolic myocardial
motion (peak of the S-wave) is measured, at a sweep speed of 100 cm/s; maximum differ-
ences ≥65 ms and the septum to lateral wall difference ≥65 ms suggest intraventricular
dyssynchrony [98, 99]. Although the method is widely available, it is hindered by the fact
that analysis of the delays is performed in different cardiac cycles and is strictly limited to
the basal area of LV walls; moreover, the method is time-consuming and measurements are
performed online, being, thus, dependant, on translational movements of the heart. All these
obstacles may result in low accuracy measurements.
• Tissue synchronization imaging
Tissue synchronization imaging is performed by the offline analysis of bidimensional
images from the apical four-, three- and two-chambers views with overlaid color tissue
Doppler, using specialized software. To acquire appropriate images, pulse repetition
frequencies, color gain, and sector depth and width should be optimized, to ensure the
highest frame rate frequency [100].
Tissue synchronization imaging allows the automatic and color-coded calculus of the time
interval from QRS onset until maximum myocardial velocity in different points. The
algorithm uses as reference points the onset of the QRS complex, either automatically
identified by the echocardiograph, or manually adjusted by the examiner, as well as the
onset and end point of the pulsed wave Doppler recording of the aortic flow, as surrogates
of systole beginning and ending. The objective of the analysis is to assess post-systolic
myocardial shortening in 2, 6, or 12 segments [101, 102]. The method requires a high degree
of training, dedicated acquisition and analysis software, which is seldom available in many
centers and is time-consuming. Yu et al. reported low interobserver and intra-observer
variability of 5.9% and 4.2%, respectively [100]; however, in their study, measurements were
most likely performed by highly skilled echocardiographers and might not be reproducible
by less experienced examiners.
• Septal flash
In the presence of LBBB, the interventricular septum has a particular two-phase active
contraction pattern, with a leftward motion occurring in the pre-ejection phase, followed by
a second excursion later in ventricular systole [103]. This particular inward/outward
movement called septal flash (Figure 5) is visible by conventional bidimensional imaging,
but is better assessed by M-mode or, preferably, by color M-mode, from the parasternal long-
axis view [104].
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Although apparently simplistic, as it does not require elaborate measurements or advanced
technology, septal flash assessment is reliable, reproducible, and a proven good predictor
of response to CRT [104], even in patients with atrial fibrillation [105] in which other imaging
mechanical dyssynchrony parameters may sometimes be difficult to assess.
• Apical rocking
Apical rocking refers to the transverse movement of the apex, due to LV enlargement and
asynchronous contraction of the interventricular septum and LV lateral wall. It can be
visually assessed from the apical four-chamber view or can be quantified using specialized
software and imaging techniques. The latter has proven superior to classical parameters of
dyssynchrony quantification in terms of identifying dyssynchrony and predicting the
response to CRT [106, 107].
Figure 3. Assessment of left intraventricular dyssynchrony. (a) Q-Mi measurement, on the pulsed wave Doppler trans-
mitral flow. Q-PW measurement, using M-mode, from the parasternal long-axis view.
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Figure 4. Assessment of left intraventricular dyssynchrony by color tissue Doppler, from the apical four-chamber view.
Maximum contraction of the left ventricle lateral wall is significantly delayed by comparison with septal contraction.
Figure 5. Septal flash evaluation by color M-mode from the parasternal long-axis view.
Interventricular dyssynchrony criteria
• A-PEP—aortic pre-ejection time, measured from QRS onset until the onset of the aortic flow
analyzed by pulsed wave Doppler, with the sample volume placed in the LV outflow tract
in the apical five-chamber view; values ≥140 ms are considered a criterion of intraventricu-
lar dyssynchrony [96].
• P-PEP—pulmonary pre-ejection time, measured from the onset of the QRS complex to the
onset on the pulmonary artery flow measured from the RV outflow tract, in the parasternal
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short-axis view; for measuring both parameters, as well as all other time-related measure-
ments, a sweep-speed of 100 cm/s should be used;
• Interventricular motion delay—the delay between the contraction of the RV and the LV,
assessed by the difference in the two pre-ejection times; values ≥40 msec suggest interven-
tricular dyssynchrony (Figure 6); Ghio et al. suggested an association between IVMD and
ventricular remodeling after CRT [81].
Figure 6. Interventricular dyssynchrony evaluation. (a) A-PEP measurement by pulsed wave Doppler from the para-
sternal short-axis-view. (b) P-PEP measurement by pulsed wave Doppler from the apical five-chamber view.
3. Multimodality imaging in the assessment of CRT patients
In CRT, procedural success depends on optimal lead placement, with reasonable stimulation
thresholds and impedances in the absence of complications such as lead displacement,
infection, coronary sinus dissection, or phrenic nerve stimulation.
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The Resynchronization Reverse Remodeling in Systolic Left Ventricular Dysfunction (RE-
VERSE) [108, 109] and SEPTAL-CRT [110] trials provided evidence that RV lead placement is
not essential for procedure success, as similar results have been reported for both apical and
mid-septal positions. However, when placing the coronary sinus lead, the optimal site for
stimulation should be chosen, provided that venous anatomy is favorable. The importance of
coronary sinus lead placement has been highlighted by several major trials. In the MADIT-
CRT study, apical placement of the LV lead was associated with poorer outcomes [111], while
in REVERSE, lead placement in the basal area of the LV posterolateral wall was associated with
more LV reverse remodeling and longer intervals until either death or first hospitalization for
HF [108].
Initially, the exact placement of the coronary sinus lead did not seem to be utterly important,
as shown by the MADIT-CRT trial [111]. However, the Targeted Left Ventricular Lead
Placement to Guide Cardiac Resynchronization Therapy (TARGET) study presented evidence
that survival was increased if LV pacing occurred in the area of maximum contraction delay,
provided there was no scar tissue on site [112]. Similar results have been reported in a smaller
study [113].
Considering the results of these large trials, imaging techniques for identifying the area of
maximal delay, the presence and location of scar tissue, and for describing venous anatomy
could be helpful. In both the TARGET trial and another smaller study, speckle tracking was
used to identify the area of maximum mechanical delay [112, 113].
Beyond cardiac ultrasonography, other imaging techniques have proved their use for targeting
the areas for optimal lead placement. CMRI, for instance, can help identify the area of maxi-
mum mechanical delay by myocardial tagging techniques [114, 115], while also providing data
on scar location [116, 117] and scar burden [118] by late gadolinium enhancement imaging, as
well as an accurate quantification of LV and RV dimensions and systolic function [119, 120].
Also, although MDCT is more widely used for this purpose, CMRI scans with ECG-triggered
respiratory-navigated three-dimensional SSFP after the injection of dimeglumine gadobenate
and ECG-triggered inversion recovery assessment can be used for venous sinus anatomy
visualization [117] (Figure 7).
Cardiac magnetic resonance imaging has been compared against speckle tracking echocar-
diography, yielding reasonable limits of agreement [121]. Some authors suggest the additive
value of echocardiographic assessment of myocardial delays by speckle tracking and CMRI
for identifying scarred areas in order to identify the best area for lead placement [122].
Although the efficiency of CMRI in assessing the response to CRT has been proved in some
studies [114, 118], its routine clinical use in patients who have already undergone the implant
procedure is somewhat hindered by the fact that, in most cases, CMRI-safe leads and devices
are not available. Also, patients with CRT-D are exposed to the risk of inappropriate shocks.
MDCT is also a reliable method in the assessment of candidates for CRT, by being able to safely
exclude significant coronary artery lesions [123], and, implicitly, the ischemic etiology of the
DCM, as well as by offering a detailed and accurate description of venus anatomy that can
help electrophysiologists in preparing the implant procedure [124, 125]; a keen study of venous
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anatomy (Figure 8), combined with the identification of the area of maximum contraction delay
by either echocardiography or CMRI, contributes to choosing the appropriate strategy before
starting the implant procedure. As a consequence, during the intervention, the electrophysi-
ologist can concentrate on the operation itself, rather than worrying over choosing the
appropriate site for stimulation.
Figure 7. Late enhancement image in a patient with clinical presentation of myocarditis; midwall late gadolinium en-
hancement is present in the interventricular septum and diffuse subepicardial enhancement is visible on the lateral
wall (arrows) in short-axis CMR views (a), four-chamber CMRI views (b) and two-chamber CMRI views (c).
Figure 8. Coronary venous anatomy using 3D volume rendered reconstructions.
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The ongoing Imaging CRT trial aims to evaluate the benefits of multimodality imaging by
speckle tracking echocardiography, single-photon emission computed tomography, and
cardiac computed tomography in identifying the optimal positions for lead placement [126].
The extensive research conducted in this field proves the interest and necessity for developing
evidence-based protocols in order to get optimum CRT results.
4. Conclusion
Despite the fact that areas of controversy still exist regarding the imaging assessment of
patients with CRT, it is undisputed that it will always have an essential role in this type of
patients. The extensive research on the topic, the fast progress and development of new
imaging techniques, as well as the possibility of skill improvement in interested examiners,
are likely to contribute to a more and more accurate assessment of the patients, thus improving
management.
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